Clinical Trial Update: Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating combinations of sirolimus, everolimus, or temsirolimus with vorinostat in patients with advanced cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Afinitor (everolimus)
• Rapamune (sirolimus)
• Torisel (Temsirolimus)
• Zolinza (vorinostat)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING